Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Ciliary landscape WP4352,0.00697175629309339,1.6869973298810583,8.377439977044423,"['DDX5', 'RALB', 'PSMD13', 'MCM9', 'COPS7B', 'HSPB11', 'EXOSC7', 'EFTUD2', 'EXOSC9', 'TCTEX1D2', 'BBS4', 'RAB2A', 'NDUFA9', 'ZYG11B', 'DYNC1H1', 'EIF5B', 'EIPR1', 'COPS4', 'IFT20', 'AFG3L2', 'COPS3', 'IFT22', 'GID4', 'IFT43', 'MSH2', 'CNOT1', 'VAPB', 'EXOC3', 'CALM2', 'CNOT9', 'CLUAP1', 'PAFAH1B1']",0.9999063297382558,0,0,32
2,Pyrimidine metabolism WP4022,0.009484933078239128,2.160972347097651,10.065918821406655,"['DUT', 'RRM1', 'CTPS2', 'NME4', 'DHODH', 'UCK2', 'POLR3A', 'POLR2A', 'POLR3C', 'POLR3D', 'POLR1C', 'TWISTNB', 'POLR1D', 'POLR3H', 'UMPS']",0.9999063297382558,0,0,15
3,Glycosylation and related congenital defects WP4521,0.01002098614106599,3.4663436255728346,15.955835423786949,"['ALG8', 'SRD5A3', 'ALG14', 'ALG3', 'ALG13', 'MAGT1', 'ALG11']",0.9999063297382558,0,0,7
4,Translation Factors WP107,0.011676412464318683,2.4537457627118644,10.919621362100484,"['EIF4A1', 'EIF5B', 'EIF2B4', 'EIF6', 'EIF2AK1', 'EIF4EBP1', 'EIF4EBP2', 'EIF2AK2', 'ETF1', 'EIF2S1', 'EIF3A']",0.9999063297382558,0,0,11
5,Intraflagellar transport proteins binding to dynein WP4532,0.015487213983191507,3.119235970250169,13.000166081606974,"['DYNC2LI1', 'DYNC1H1', 'IFT22', 'DYNC1LI2', 'IFT43', 'TCTEX1D2', 'HSPB11']",0.9999063297382558,0,0,7
6,Cytosolic DNA-sensing pathway WP4655,0.02971995769672301,2.2921752587290842,8.059142616513272,"['NLRX1', 'POLR3A', 'POLR3C', 'POLR3D', 'POLR1C', 'POLR1D', 'TRIM25', 'POLR2F', 'POLR3H']",0.9999063297382558,0,0,9
7,Immune response to tuberculosis WP4197,0.03668162860541334,3.180042442365197,10.511564250796784,"['IFNGR2', 'IFIT1', 'PSMB8', 'PTPN2', 'IRF9']",0.9999063297382558,0,0,5
8,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.039225603944161455,5.3389076196898175,17.289655023878797,"['ZYG11B', 'CUL2', 'RBX1']",0.9999063297382558,0,0,3
9,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.039225603944161455,5.3389076196898175,17.289655023878797,"['UBE2N', 'UBE2V1', 'PRKCZ']",0.9999063297382558,0,0,3
10,Mitochondrial CII Assembly WP4920,0.039225603944161455,5.3389076196898175,17.289655023878797,"['SDHAF3', 'SDHAF4', 'SDHC']",0.9999063297382558,0,0,3
11,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.0457135260485131,3.5603238866396762,10.98488464547378,"['RPH3A', 'RAB27A', 'GCC2', 'UNC13D']",0.9999063297382558,0,0,4
12,Type II interferon signaling (IFNG) WP619,0.054271630743061246,2.7821151249155975,8.106398079511754,"['IFNGR2', 'IFI6', 'EIF2AK2', 'PTPN11', 'IRF9']",0.9999063297382558,0,0,5
13,Proteasome Degradation WP183,0.05808077011585862,1.896154067923658,5.39630401555693,"['PSMA3', 'PSMA4', 'PSMD4', 'PSMA1', 'RPN2', 'PSMB2', 'PSMA2', 'PSMD13', 'HLA-C', 'PSMB8']",0.9999063297382558,0,0,10
14,Mitochondrial complex I assembly model OXPHOS system WP4324,0.06114825677528151,1.9558432551150156,5.465513860177464,"['NDUFB8', 'TIMMDC1', 'NDUFB6', 'ACAD9', 'NDUFAB1', 'NDUFS1', 'NDUFV3', 'TMEM186', 'FOXRED1']",0.9999063297382558,0,0,9
15,DNA IR-double strand breaks and cellular response via ATM WP3959,0.06789028733034502,1.909130476835284,5.135298092336877,"['CASP9', 'RASSF1', 'DCLRE1C', 'PARP1', 'PRKDC', 'HSF1', 'RNF8', 'RAD17', 'TERF2']",0.9999063297382558,0,0,9
16,Iron metabolism in placenta WP2007,0.07216842967766088,3.812927463635488,10.023242948535882,"['TFR2', 'FTH1', 'MCOLN1']",0.9999063297382558,0,0,3
17,Non-homologous end joining WP438,0.07216842967766088,3.812927463635488,10.023242948535882,"['DCLRE1C', 'PRKDC', 'XRCC5']",0.9999063297382558,0,0,3
18,Fluoropyrimidine Activity WP1601,0.07596596566029126,2.4726161002325755,6.373093471861985,"['ABCC4', 'RRM1', 'UCK2', 'GGH', 'UMPS']",0.9999063297382558,0,0,5
19,RAS and bradykinin pathways in COVID-19 WP4969,0.0920150490719218,3.33605866486851,7.959179232668648,"['SERPING1', 'NOS1', 'RHOA']",0.9999063297382558,0,0,3
20,Biomarkers for pyrimidine metabolism disorders WP4584,0.11382088346451322,2.965160710271971,6.443677511637384,"['RRM1', 'UMPS', 'DHODH']",0.9999063297382558,0,0,3
21,Pilocytic astrocytoma WP2253,0.1165572836590049,4.446428571428571,9.557030946026293,"['PTPN11', 'GRB2']",0.9999063297382558,0,0,2
22,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.11865625107986104,2.3726495726495727,5.0573609608199,"['BECN1', 'ATG16L1', 'ULK2', 'WIPI1']",0.9999063297382558,0,0,4
23,p53 transcriptional gene network WP4963,0.1279163264619305,1.6958566917971518,3.4873239664848112,"['PRKAB2', 'MSH2', 'XRCC5', 'MGMT', 'FUCA1', 'ULK2', 'IRF9', 'PML']",0.9999063297382558,0,0,8
24,Pre-implantation embryo WP3527,0.13109282954857127,2.0224357006936344,4.109285137580587,"['EGR1', 'CDH1', 'FOSB', 'SOX11', 'ELAVL1']",0.9999063297382558,0,0,5
25,mRNA Processing WP411,0.13410670030599325,1.3899738322893311,2.7926235656171956,"['SF3B2', 'TMED10', 'SF3B3', 'DDX1', 'CPSF3', 'SRP54', 'HNRNPR', 'CLK3', 'EFTUD2', 'HNRNPM', 'PRPF6', 'HNRNPK', 'POLR2A', 'SNRPA1', 'HNRNPC', 'SF3B1', 'RBMX']",0.9999063297382558,0,0,17
26,Fas ligand pathway and stress induction of heat shock proteins WP314,0.1368456050805513,1.8413793103448275,3.6623229173811613,"['CASP9', 'DFFA', 'PARP1', 'PRKDC', 'CFLAR', 'SPTAN1']",0.9999063297382558,0,0,6
27,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.13734355211889956,2.6684423465947402,5.297578036920797,"['JAG1', 'H2AFY', 'CDH1']",0.9999063297382558,0,0,3
28,NOTCH1 regulation of endothelial cell calcification WP3413,0.13734355211889956,2.6684423465947402,5.297578036920797,"['JAG1', 'LPAR1', 'DLL1']",0.9999063297382558,0,0,3
29,Omega-3/Omega-6 FA synthesis WP4723,0.13734355211889956,2.6684423465947402,5.297578036920797,"['ACOT2', 'ACOX3', 'PLA2G6']",0.9999063297382558,0,0,3
30,Pyrimidine metabolism and related diseases WP4225,0.13734355211889956,2.6684423465947402,5.297578036920797,"['RRM1', 'UMPS', 'DHODH']",0.9999063297382558,0,0,3
31,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.13900983890667845,1.7308053489595072,3.4152434002747825,"['MECP2', 'BECN1', 'ATG16L1', 'WIPI1', 'PLA2G6', 'WDR45', 'GTPBP2']",0.9999063297382558,0,0,7
32,Genes related to primary cilium development (based on CRISPR) WP4536,0.13955041407495491,1.4336269365317342,2.823283605626544,"['MKKS', 'FBF1', 'TXNDC15', 'HSPB11', 'DYNC2LI1', 'IFT20', 'TMEM17', 'IFT43', 'TCTN3', 'TCTEX1D2', 'TCTN1', 'CEP83', 'CLUAP1', 'BBS4']",0.9999063297382558,0,0,14
33,"Cerebral organic acidurias, including diseases WP4519",0.15258944694977003,3.556873315363881,6.686937189702221,"['GCDH', 'IDH2']",0.9999063297382558,0,0,2
34,Estrogen metabolism WP697,0.15258944694977003,3.556873315363881,6.686937189702221,"['SULT1A1', 'ARSD']",0.9999063297382558,0,0,2
35,Serotonin Transporter Activity WP1455,0.15258944694977003,3.556873315363881,6.686937189702221,"['PPP2CB', 'NOS1']",0.9999063297382558,0,0,2
36,Fatty Acid Biosynthesis WP357,0.15656348309176857,2.0931967928871953,3.881401643690139,"['MECR', 'ECH1', 'ECHDC1', 'ECHDC2']",0.9999063297382558,0,0,4
37,Unfolded protein response WP4925,0.15656348309176857,2.0931967928871953,3.881401643690139,"['ERN1', 'MBTPS1', 'RTCB', 'EIF2S1']",0.9999063297382558,0,0,4
38,NAD+ metabolism WP3644,0.1623335686784214,2.4256727763133696,4.410120513357834,"['NT5E', 'PARP1', 'SIRT6']",0.9999063297382558,0,0,3
39,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.16650728082144353,1.4248032564450475,2.554267939284611,"['NDUFA9', 'SURF1', 'NDUFB8', 'SCO1', 'NDUFB6', 'COX15', 'NDUFAB1', 'SDHC', 'NDUFS1', 'UQCRC2', 'NDUFV3', 'ATP5MG']",0.9999063297382558,0,0,12
40,Nanoparticle triggered autophagic cell death WP2509,0.1769979926498771,1.9767581346528715,3.4229877683369776,"['BECN1', 'ATG16L1', 'ATG9B', 'ULK2']",0.9999063297382558,0,0,4
41,Base Excision Repair WP4752,0.1813738664119889,1.7793382849426063,3.0376770991060815,"['MBD4', 'PARP1', 'MPG', 'LIG3', 'MUTYH']",0.9999063297382558,0,0,5
42,Lung fibrosis WP3624,0.1813738664119889,1.7793382849426063,3.0376770991060815,"['MECP2', 'PDGFA', 'ATP11A', 'IGF1', 'FGF1']",0.9999063297382558,0,0,5
43,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.18854189419828657,2.223364801078894,3.709539755050507,"['EGLN2', 'CFLAR', 'BIRC2']",0.9999063297382558,0,0,3
44,ATR Signaling WP3875,0.1903774082100072,2.9638364779874213,4.916254327005282,"['RPA1', 'HUS1']",0.9999063297382558,0,0,2
45,Caloric restriction and aging WP4191,0.1903774082100072,2.9638364779874213,4.916254327005282,"['PRKAB2', 'IGF1']",0.9999063297382558,0,0,2
46,Arylamine metabolism WP694,0.1921246928820623,8.88888888888889,14.663206005835876,['SULT1A1'],0.9999063297382558,0,0,1
47,16p11.2 distal deletion syndrome WP4950,0.1982678967653386,1.8725761772853187,3.0300832038842596,"['ATP2A1', 'TRAF2', 'GRB2', 'SH2B1']",0.9999063297382558,0,0,4
48,BDNF-TrkB Signaling WP3676,0.1995252482097551,1.7107723471666754,2.757447663759062,"['ARC', 'TRPC3', 'HOMER1', 'EIF4EBP1', 'GRB2']",0.9999063297382558,0,0,5
49,DNA IR-damage and cellular response via ATR WP4016,0.20027560166575167,1.4128704779111283,2.271981705446741,"['PARP1', 'MSH2', 'PRKDC', 'XRCC5', 'RBBP8', 'RPA1', 'HUS1', 'RPA2', 'RAD17', 'PML']",0.9999063297382558,0,0,10
50,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.2157256699727059,2.0521811297266455,3.1475281388278544,"['SETX', 'RBBP4', 'THRAP3']",0.9999063297382558,0,0,3
51,Kynurenine Pathway and links to Cellular Senescence WP5044,0.2157256699727059,2.0521811297266455,3.1475281388278544,"['EIF2AK1', 'NOS1', 'KMO']",0.9999063297382558,0,0,3
52,Urea cycle and metabolism of amino groups WP497,0.2157256699727059,2.0521811297266455,3.1475281388278544,"['ACY1', 'SMS', 'PYCR3']",0.9999063297382558,0,0,3
53,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.22025622788549584,1.7788124156545209,2.691278681816271,"['CDH1', 'PDGFA', 'FGF1', 'GTPBP4']",0.9999063297382558,0,0,4
54,15q11.2 copy number variation syndrome WP4940,0.22919766348546255,2.540238737004236,3.742204740871849,"['TUBGCP2', 'TUBGCP4']",0.9999063297382558,0,0,2
55,Cytosine methylation WP3585,0.22919766348546255,2.540238737004236,3.742204740871849,"['MECP2', 'IDH2']",0.9999063297382558,0,0,2
56,Purine metabolism WP4792,0.22919766348546255,2.540238737004236,3.742204740871849,"['DGUOK', 'ATIC']",0.9999063297382558,0,0,2
57,Thiamine metabolic pathways WP4297,0.22919766348546255,2.540238737004236,3.742204740871849,"['PDHA1', 'SLC25A19']",0.9999063297382558,0,0,2
58,Vitamin B12 Disorders WP4271,0.22919766348546255,2.540238737004236,3.742204740871849,"['MMAB', 'MMACHC']",0.9999063297382558,0,0,2
59,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.2293065183637616,1.4236535859269284,2.096608460601981,"['CASP9', 'MSH2', 'TNIP1', 'EIF4EBP1', 'PTPN11', 'GRB2', 'NOS1', 'CRK']",0.9999063297382558,0,0,8
60,Parkinson's disease pathway WP2371,0.23750693854927274,1.5883331725667984,2.2833217593276416,"['CASP9', 'CCNE2', 'PARK7', 'UBE2G2', 'UBE2J2']",0.9999063297382558,0,0,5
61,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.24284589202710427,1.6939785360837993,2.397535636380407,"['RAB4B', 'SH3TC2', 'HSPB8', 'MPZ']",0.9999063297382558,0,0,4
62,Oxidative Stress WP408,0.24284589202710427,1.6939785360837993,2.397535636380407,"['NFIX', 'TXNRD1', 'FOS', 'JUNB']",0.9999063297382558,0,0,4
63,ATM Signaling Network in Development and Disease  WP3878,0.24781756569273955,1.482545045045045,2.068242886789537,"['DCLRE1C', 'PRKDC', 'RASGRF1', 'RNF8', 'RBBP8', 'RNF40']",0.9999063297382558,0,0,6
64,Eukaryotic Transcription Initiation WP405,0.24781756569273955,1.482545045045045,2.068242886789537,"['POLR2A', 'TAF12', 'POLR3D', 'POLR1D', 'POLR2F', 'POLR3H']",0.9999063297382558,0,0,6
65,Oxidative phosphorylation WP623,0.2542437703906086,1.4152529350298113,1.9381347558038484,"['NDUFA9', 'NDUFB8', 'NDUFB6', 'NDUFAB1', 'NDUFS1', 'NDUFV3', 'ATP5MG']",0.9999063297382558,0,0,7
66,Target Of Rapamycin (TOR) Signaling WP1471,0.2571953698550867,1.5334466460220262,2.082296779131322,"['PRKAB2', 'RRAGC', 'RRAGD', 'EIF4EBP1', 'ULK2']",0.9999063297382558,0,0,5
67,Amino Acid metabolism WP3925,0.2607356030896384,1.3345633039945837,1.793984586211049,"['PDHA1', 'RARS', 'GSS', 'GOT2', 'SMS', 'IARS', 'HNMT', 'BCAT1', 'ADH5']",0.9999063297382558,0,0,9
68,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.2654620612874132,1.4423666910153397,1.9129869180176344,"['ERN1', 'MBTPS1', 'PPP1R10', 'EIF2AK1', 'EIF2AK2', 'EIF2S1']",0.9999063297382558,0,0,6
69,Oxysterols derived from cholesterol WP4545,0.2659212966097741,1.6168568273831432,2.141615619383873,"['NR1H2', 'ACOT2', 'ACOT13', 'SLC27A2']",0.9999063297382558,0,0,4
70,Trans-sulfuration and one-carbon metabolism WP2525,0.2659212966097741,1.6168568273831432,2.141615619383873,"['MTHFD1', 'GSS', 'MTHFD2L', 'AMT']",0.9999063297382558,0,0,4
71,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.26845497383893224,2.222540431266846,2.9228008551509004,"['JAG1', 'VHL']",0.9999063297382558,0,0,2
72,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.26845497383893224,2.222540431266846,2.9228008551509004,"['UBE2N', 'UBE2V1']",0.9999063297382558,0,0,2
73,let-7 inhibition of ES cell reprogramming WP3299,0.2738748569439285,4.444107744107744,5.755492848812833,['EGR1'],0.9999063297382558,0,0,1
74,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.2738748569439285,4.444107744107744,5.755492848812833,['CCKBR'],0.9999063297382558,0,0,1
75,Spinal Cord Injury WP2431,0.2751723494367442,1.2894230391579278,1.6638168857599445,"['EGR1', 'NR4A1', 'SEMA6A', 'PTPRA', 'NCAN', 'OMG', 'NOS1', 'FOS', 'PLA2G6', 'RHOA']",0.9999063297382558,0,0,10
76,DNA Repair Pathways Full Network WP4946,0.2831969910756661,1.2214007885763,1.540934553617719,"['MBD4', 'DCLRE1C', 'PARP1', 'MPG', 'PRKDC', 'XRCC5', 'MGMT', 'RPA1', 'RPA2', 'LIG3', 'TERF2', 'RBX1', 'MSH2', 'MUTYH']",0.9999063297382558,0,0,14
77,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.2834103183441957,1.404302987197724,1.7706288230505487,"['CHP1', 'AHSA1', 'GRB2', 'FOS', 'MAP2K7', 'CALM2']",0.9999063297382558,0,0,6
78,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.2882813049829161,1.3177968225329524,1.6391000962923,"['TUBB8', 'PSMD4', 'PSMD13', 'HSPA4', 'STUB1', 'UBE2G2', 'UBE2J2', 'TUBA4A']",0.9999063297382558,0,0,8
79,Glycogen Synthesis and Degradation WP500,0.29761105690498846,1.4342967916185663,1.738321560267163,"['GYS2', 'PPP2CB', 'PHKG2', 'PPP2R5D', 'CALM2']",0.9999063297382558,0,0,5
80,Kallmann's Syndrome WP5074,0.3008745758788623,1.6670178691840862,2.0021914701011245,"['PTPN11', 'GRB2', 'FGFR1']",0.9999063297382558,0,0,3
81,Alzheimer's disease WP2059,0.3030185630471887,1.2707225070122836,1.5171933835298073,"['CASP9', 'ERN1', 'MME', 'ATP2A2', 'CHP1', 'ATP2A1', 'NOS1', 'MAPT', 'CALM2']",0.9999063297382558,0,0,9
82,Alanine and aspartate metabolism WP106,0.3076638433845673,1.9754417490266547,2.328547042066569,"['DARS', 'GOT2']",0.9999063297382558,0,0,2
83,Cancer immunotherapy by PD-1 blockade WP4585,0.3076638433845673,1.9754417490266547,2.328547042066569,"['PTPN11', 'PDCD1LG2']",0.9999063297382558,0,0,2
84,Cysteine and methionine catabolism WP4504,0.3076638433845673,1.9754417490266547,2.328547042066569,"['GSS', 'ETHE1']",0.9999063297382558,0,0,2
85,Disorders of Folate Metabolism and Transport WP4259,0.3076638433845673,1.9754417490266547,2.328547042066569,"['ATIC', 'MTHFD1']",0.9999063297382558,0,0,2
86,Ganglio Sphingolipid Metabolism WP1423,0.3076638433845673,1.9754417490266547,2.328547042066569,"['ST8SIA3', 'ST3GAL5']",0.9999063297382558,0,0,2
87,Serotonin and anxiety-related events WP3944,0.3076638433845673,1.9754417490266547,2.328547042066569,"['ARC', 'FOS']",0.9999063297382558,0,0,2
88,Gastrin signaling pathway WP4659,0.3106215809361117,1.213118292833354,1.4183535112481533,"['EGR1', 'JAG1', 'CCKBR', 'CDH1', 'EIF4EBP1', 'GRB2', 'PTPN11', 'FOS', 'ELAVL1', 'CRK', 'RHOA', 'BIRC2']",0.9999063297382558,0,0,12
89,Metapathway biotransformation Phase I and II WP702,0.3106215809361117,1.213118292833354,1.4183535112481533,"['SULT1A1', 'GSTZ1', 'CYP4Z1', 'GAL3ST1', 'CHST7', 'GSS', 'CHST10', 'CYP20A1', 'AKR1A1', 'CHST1', 'HNMT', 'NAT9']",0.9999063297382558,0,0,12
90,Monoamine Transport WP727,0.32977961762803215,1.5688389988497085,1.7403612224004787,"['PPP2CB', 'NOS1', 'NECTIN2']",0.9999063297382558,0,0,3
91,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.32977961762803215,1.5688389988497085,1.7403612224004787,"['PARP1', 'GOT2', 'ELAVL1']",0.9999063297382558,0,0,3
92,Striated Muscle Contraction Pathway WP383,0.32977961762803215,1.5688389988497085,1.7403612224004787,"['TPM4', 'TPM1', 'TTN']",0.9999063297382558,0,0,3
93,Ciliopathies WP4803,0.3334966841901132,1.1439178668742702,1.256161783196115,"['GALNT11', 'MKKS', 'DNAAF1', 'PKD1L1', 'CFAP410', 'KIF7', 'POMGNT1', 'DYNC2LI1', 'TMEM17', 'IFT43', 'TMEM138', 'TCTN3', 'TCTEX1D2', 'TCTN1', 'CEP83', 'CLUAP1', 'TRIM32', 'BBS4']",0.9999063297382558,0,0,18
94,Differentiation Pathway WP2848,0.33695574367180847,1.4225101214574898,1.5474117473336988,"['NT5E', 'PDGFA', 'IGF1', 'FGF1']",0.9999063297382558,0,0,4
95,Glycolysis and Gluconeogenesis WP534,0.33695574367180847,1.4225101214574898,1.5474117473336988,"['PDHA1', 'MPC2', 'GOT2', 'SLC2A3']",0.9999063297382558,0,0,4
96,Genotoxicity pathway WP4286,0.33858637551002435,1.3012524719841794,1.4092252593081325,"['COIL', 'PRKAB2', 'NLRX1', 'CEBPD', 'ID2', 'TM7SF3']",0.9999063297382558,0,0,6
97,PDGF Pathway WP2526,0.3389470179505859,1.3471651013852228,1.4575133792777786,"['PDGFA', 'PTPN11', 'GRB2', 'FOS', 'RHOA']",0.9999063297382558,0,0,5
98,Cell Differentiation - Index expanded WP2023,0.34643242900167254,1.7777628032345014,1.8845485516895983,"['HDAC5', 'ID2']",0.9999063297382558,0,0,2
99,Corticotropin-releasing hormone signaling pathway WP2355,0.34675482870536367,1.2126854188465563,1.2844003533225274,"['CASP9', 'ERN1', 'GNAO1', 'NR4A1', 'PARP1', 'FOSB', 'FOS', 'JUNB', 'RHOA']",0.9999063297382558,0,0,9
100,Effects of nitric oxide WP1995,0.3473575906498913,2.9625140291806957,3.1325638425300975,['NOS1'],0.9999063297382558,0,0,1
101,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.3473575906498913,2.9625140291806957,3.1325638425300975,['GSS'],0.9999063297382558,0,0,1
102,Gene regulatory network modelling somitogenesis  WP2854,0.3473575906498913,2.9625140291806957,3.1325638425300975,['DLL1'],0.9999063297382558,0,0,1
103,Hypothetical Craniofacial Development Pathway WP3655,0.3473575906498913,2.9625140291806957,3.1325638425300975,['RHOA'],0.9999063297382558,0,0,1
104,Acute viral myocarditis WP4298,0.3540435430052095,1.2448546315077755,1.2925765951161623,"['CASP9', 'DFFA', 'CXADR', 'PARP1', 'SGCB', 'DAG1', 'NOS1']",0.9999063297382558,0,0,7
105,Splicing factor NOVA regulated synaptic proteins WP4148,0.3806719268398153,1.2699913186071188,1.2265796615586702,"['CADM3', 'DAB1', 'EPB41L1', 'MAP4', 'PRKCZ']",0.9999063297382558,0,0,5
106,Airway smooth muscle cell contraction WP4962,0.3844485789004217,1.6160254839500123,1.544831859338552,"['CALM2', 'RHOA']",0.9999063297382558,0,0,2
107,Alpha 6 Beta 4 signaling pathway WP244,0.38479750417244746,1.3169390713250362,1.2577269177084969,"['EIF4EBP1', 'PTPN11', 'GRB2', 'RHOA']",0.9999063297382558,0,0,4
108,Myometrial relaxation and contraction pathways WP289,0.3857885339166275,1.1215971406188798,1.0682830291138918,"['YWHAE', 'RGS17', 'CRCP', 'LPAR1', 'ATP2A2', 'ADCY3', 'FOS', 'PRKCZ', 'MAFF', 'GNB4', 'PDE4B', 'NOS1', 'CALM2', 'YWHAH']",0.9999063297382558,0,0,14
109,7-oxo-C and 7beta-HC pathways WP5064,0.3873306927421287,1.4034851119707563,1.3311725732934292,"['ACOT2', 'ACOT13', 'SLC27A2']",0.9999063297382558,0,0,3
110,Physiological and pathological hypertrophy of the heart WP1528,0.3873306927421287,1.4034851119707563,1.3311725732934292,"['FOS', 'CALM2', 'RHOA']",0.9999063297382558,0,0,3
111,Fragile X Syndrome  WP4549,0.3920118930335657,1.1222984596523837,1.0509910949661716,"['EIF4A1', 'SLC16A1', 'HOMER1', 'CLTC', 'PTPN11', 'ALDH3A2', 'MECP2', 'ARC', 'DAG1', 'EIF4EBP2', 'GRB2', 'PTPN5', 'TELO2']",0.9999063297382558,0,0,13
112,Kit receptor signaling pathway WP304,0.3947592694384059,1.2122542997542998,1.1267650892429715,"['PTPN11', 'GRB2', 'FOS', 'MAPT', 'JUNB', 'CRK']",0.9999063297382558,0,0,6
113,IL-2 signaling pathway WP49,0.4085886005611428,1.2698091382301908,1.1365382194586158,"['PTPN11', 'GRB2', 'FOS', 'MAPT']",0.9999063297382558,0,0,4
114,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.4085886005611428,1.2698091382301908,1.1365382194586158,"['GABRA6', 'GABRA3', 'AP2A2', 'RHOA']",0.9999063297382558,0,0,4
115,Acetylcholine Synthesis WP528,0.4134084726608716,2.2217171717171715,1.9624852945061766,['PDHA1'],0.9999063297382558,0,0,1
116,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.4134084726608716,2.2217171717171715,1.9624852945061766,['ACOT2'],0.9999063297382558,0,0,1
117,miR-517 relationship with ARCN1 and USP1 WP3596,0.4134084726608716,2.2217171717171715,1.9624852945061766,['ID2'],0.9999063297382558,0,0,1
118,Mitochondrial fatty acid synthesis pathway WP4317,0.4134084726608716,2.2217171717171715,1.9624852945061766,['MECR'],0.9999063297382558,0,0,1
119,"Phase I biotransformations, non P450 WP136",0.4134084726608716,2.2217171717171715,1.9624852945061766,['ESD'],0.9999063297382558,0,0,1
120,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.4134084726608716,2.2217171717171715,1.9624852945061766,['DLL1'],0.9999063297382558,0,0,1
121,DNA Mismatch Repair WP531,0.41569010310596854,1.3332097100472016,1.1703118026442232,"['MSH2', 'RPA1', 'RPA2']",0.9999063297382558,0,0,3
122,MTHFR deficiency WP4288,0.41569010310596854,1.3332097100472016,1.1703118026442232,"['CASP9', 'EHMT2', 'HNMT']",0.9999063297382558,0,0,3
123,GDNF/RET signaling axis WP4830,0.4214677350683185,1.4812443845462713,1.2798130007249005,"['SOX11', 'HSPB11']",0.9999063297382558,0,0,2
124,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.4214677350683185,1.4812443845462713,1.2798130007249005,"['PDHA1', 'SLC2A3']",0.9999063297382558,0,0,2
125,Serotonin and anxiety WP3947,0.4214677350683185,1.4812443845462713,1.2798130007249005,"['ARC', 'FOS']",0.9999063297382558,0,0,2
126,Transcription co-factors SKI and SKIL protein partners WP4533,0.4214677350683185,1.4812443845462713,1.2798130007249005,"['MECP2', 'ING2']",0.9999063297382558,0,0,2
127,Type II diabetes mellitus WP1584,0.4214677350683185,1.4812443845462713,1.2798130007249005,"['SURF1', 'PRKCZ']",0.9999063297382558,0,0,2
128,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.422296834693975,1.2011606474807015,1.0354567074215684,"['TRAF2', 'FOS', 'CFLAR', 'MAP2K7', 'JUNB']",0.9999063297382558,0,0,5
129,Type 2 papillary renal cell carcinoma WP4241,0.43218606307071317,1.225929545348783,1.028431170080345,"['EGLN2', 'CUL2', 'VHL', 'RBX1']",0.9999063297382558,0,0,4
130,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.43976530938439545,1.131255762493085,0.9293425393837849,"['GNAO1', 'EGR1', 'ADCY3', 'TTF2', 'FOS', 'TTF1', 'RALGDS']",0.9999063297382558,0,0,7
131,Photodynamic therapy-induced unfolded protein response WP3613,0.4436092177602676,1.2696272035449379,1.0319672670854452,"['ERN1', 'TRIB3', 'EIF2A']",0.9999063297382558,0,0,3
132,DNA Replication WP466,0.4555181465094647,1.1849752586594693,0.9317694188289222,"['ORC6', 'ORC3', 'RPA1', 'RPA2']",0.9999063297382558,0,0,4
133,IL-5 signaling pathway WP127,0.4555181465094647,1.1849752586594693,0.9317694188289222,"['PTPN11', 'GRB2', 'FOS', 'MAPT']",0.9999063297382558,0,0,4
134,Signaling of Hepatocyte Growth Factor Receptor WP313,0.4555181465094647,1.1849752586594693,0.9317694188289222,"['PTPN11', 'GRB2', 'FOS', 'CRK']",0.9999063297382558,0,0,4
135,Apoptosis WP254,0.4567858916337836,1.110970250169033,0.870490192337571,"['CASP9', 'DFFA', 'TRAF2', 'IGF1', 'CFLAR', 'TNFRSF21', 'BIRC2']",0.9999063297382558,0,0,7
136,Overview of interferons-mediated signaling pathway WP4558,0.4573024653179988,1.367198838896952,1.0697103953253215,"['IFNGR2', 'IRF9']",0.9999063297382558,0,0,2
137,DNA damage response WP707,0.46916403567001613,1.1108952702702704,0.8407286682220285,"['CASP9', 'CCNE2', 'PRKDC', 'RPA2', 'RAD17', 'PML']",0.9999063297382558,0,0,6
138,Gastric Cancer Network 2 WP2363,0.4709860232837034,1.2118249249065163,0.9124155355346533,"['RAD17', 'BRIX1', 'CACYBP']",0.9999063297382558,0,0,3
139,Hematopoietic Stem Cell Differentiation WP2849,0.4709860232837034,1.2118249249065163,0.9124155355346533,"['ZNF835', 'FOSB', 'FOS']",0.9999063297382558,0,0,3
140,Sphingolipid pathway WP1422,0.4709860232837034,1.2118249249065163,0.9124155355346533,"['UGCG', 'GAL3ST1', 'KDSR']",0.9999063297382558,0,0,3
141,Benzo(a)pyrene metabolism WP696,0.4727786843849426,1.7772390572390573,1.3313793586504867,['AKR1A1'],0.9999063297382558,0,0,1
142,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.4727786843849426,1.7772390572390573,1.3313793586504867,['ID2'],0.9999063297382558,0,0,1
143,Drug Induction of Bile Acid Pathway WP2289,0.4727786843849426,1.7772390572390573,1.3313793586504867,['ABCC4'],0.9999063297382558,0,0,1
144,exRNA mechanism of action and biogenesis WP2805,0.4727786843849426,1.7772390572390573,1.3313793586504867,['XPO5'],0.9999063297382558,0,0,1
145,Fluoroacetic acid toxicity WP4966,0.4727786843849426,1.7772390572390573,1.3313793586504867,['ALDH3A2'],0.9999063297382558,0,0,1
146,Methylation Pathways WP704,0.4727786843849426,1.7772390572390573,1.3313793586504867,['HNMT'],0.9999063297382558,0,0,1
147,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.4727786843849426,1.7772390572390573,1.3313793586504867,['CTDSP1'],0.9999063297382558,0,0,1
148,miRNA Biogenesis WP2338,0.4727786843849426,1.7772390572390573,1.3313793586504867,['XPO5'],0.9999063297382558,0,0,1
149,Molybdenum cofactor (Moco) biosynthesis WP4507,0.4727786843849426,1.7772390572390573,1.3313793586504867,['MOCS1'],0.9999063297382558,0,0,1
150,Small Ligand GPCRs WP247,0.4727786843849426,1.7772390572390573,1.3313793586504867,['LPAR1'],0.9999063297382558,0,0,1
151,Tamoxifen metabolism WP691,0.4727786843849426,1.7772390572390573,1.3313793586504867,['SULT1A1'],0.9999063297382558,0,0,1
152,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.4774075909948135,1.0772132693648255,0.7964749717669475,"['CASP9', 'PRKG2', 'ADCY3', 'SIRT6', 'GRB2', 'TTF2', 'TTF1', 'FGFR1']",0.9999063297382558,0,0,8
153,Prader-Willi and Angelman Syndrome WP3998,0.48360603939547653,1.110820391627279,0.8069939877607827,"['FEZ2', 'MKRN3', 'ATP10A', 'PRKCZ', 'BBS4']",0.9999063297382558,0,0,5
154,3q29 copy number variation syndrome WP4906,0.48741974841818947,1.0881412024269168,0.7819704995950003,"['DYNC2LI1', 'TCTEX1D2', 'RNF8', 'UBE2N', 'PIGZ', 'WDR53']",0.9999063297382558,0,0,6
155,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.4904672560294689,1.0724977267958313,0.7640439040851198,"['MBTPS1', 'SEC13', 'PRKAB2', 'SAR1A', 'NR1H2', 'SEC23B', 'SEC31A']",0.9999063297382558,0,0,7
156,Pregnane X receptor pathway WP2876,0.49181341962097064,1.2694455140546785,0.9008694515893141,"['ABCC4', 'DNAJC7']",0.9999063297382558,0,0,2
157,Endothelin Pathways WP2197,0.49773358357440745,1.159048931367088,0.8086572173275971,"['EDNRA', 'ATP2A2', 'CALM2']",0.9999063297382558,0,0,3
158,One-carbon metabolism WP241,0.49773358357440745,1.159048931367088,0.8086572173275971,"['ATIC', 'MTHFD1', 'AMT']",0.9999063297382558,0,0,3
159,NO/cGMP/PKG mediated Neuroprotection WP4008,0.5011336135041532,1.1107456140350878,0.7673947287176035,"['CASP9', 'PRKG2', 'NOS1', 'CALM2']",0.9999063297382558,0,0,4
160,miRNA regulation of DNA damage response WP1530,0.5054698469542112,1.0662972972972973,0.727499343234087,"['CASP9', 'CCNE2', 'PRKDC', 'RPA2', 'RAD17', 'PML']",0.9999063297382558,0,0,6
161,Proximal tubule transport WP4917,0.5233076081149688,1.0770048664785508,0.697453087124654,"['ABCC4', 'SLC22A6', 'SLC1A1', 'SLC3A1']",0.9999063297382558,0,0,4
162,Constitutive Androstane Receptor Pathway WP2875,0.5249015297788653,1.1847259658580414,0.7636087194001655,"['SULT1A1', 'DNAJC7']",0.9999063297382558,0,0,2
163,"GPCRs, Class B Secretin-like WP334",0.5249015297788653,1.1847259658580414,0.7636087194001655,"['ADCYAP1R1', 'VIPR2']",0.9999063297382558,0,0,2
164,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.5249015297788653,1.1847259658580414,0.7636087194001655,"['RAB5B', 'RAB27A']",0.9999063297382558,0,0,2
165,Nanomaterial induced apoptosis WP2507,0.5249015297788653,1.1847259658580414,0.7636087194001655,"['CASP9', 'CFLAR']",0.9999063297382558,0,0,2
166,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.5249015297788653,1.1847259658580414,0.7636087194001655,"['EIF2S1', 'EIF3A']",0.9999063297382558,0,0,2
167,Aspirin and miRNAs WP4707,0.5261435274318811,1.4809203142536476,0.9510192402320949,['ABCC4'],0.9999063297382558,0,0,1
168,DDX1 as a regulatory component of the Drosha microprocessor WP2942,0.5261435274318811,1.4809203142536476,0.9510192402320949,['DDX1'],0.9999063297382558,0,0,1
169,Dual hijack model of Vif in HIV infection WP3300,0.5261435274318811,1.4809203142536476,0.9510192402320949,['RBX1'],0.9999063297382558,0,0,1
170,Ketogenesis and Ketolysis WP4742,0.5261435274318811,1.4809203142536476,0.9510192402320949,['SLC16A1'],0.9999063297382558,0,0,1
171,LDLRAD4 and what we know about it WP4904,0.5261435274318811,1.4809203142536476,0.9510192402320949,['ATG16L1'],0.9999063297382558,0,0,1
172,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5261435274318811,1.4809203142536476,0.9510192402320949,['CDH1'],0.9999063297382558,0,0,1
173,NAD Biosynthesis II (from tryptophan) WP2485,0.5261435274318811,1.4809203142536476,0.9510192402320949,['KMO'],0.9999063297382558,0,0,1
174,Sulfation Biotransformation Reaction WP692,0.5261435274318811,1.4809203142536476,0.9510192402320949,['SULT1A1'],0.9999063297382558,0,0,1
175,Type III interferon signaling WP2113,0.5261435274318811,1.4809203142536476,0.9510192402320949,['IRF9'],0.9999063297382558,0,0,1
176,Insulin Signaling WP481,0.53756513230321,1.0019269792428045,0.6219014362687572,"['CAP1', 'EGR1', 'STXBP3', 'PTPN11', 'FOS', 'PRKCZ', 'GYS2', 'EIF4EBP1', 'TRIB3', 'GRB2', 'SGK3', 'MAP2K7', 'MAP3K13', 'SGK2', 'CRK']",0.9999063297382558,0,0,15
177,Pathogenic Escherichia coli infection WP2272,0.5424891012272451,1.0330857528696826,0.631822109398869,"['TUBB8', 'ARPC2', 'CDH1', 'TUBA4A', 'RHOA']",0.9999063297382558,0,0,5
178,Phosphodiesterases in neuronal function WP4222,0.5424891012272451,1.0330857528696826,0.631822109398869,"['PDE10A', 'PDE1C', 'PDE4B', 'ADCY3', 'NOS1']",0.9999063297382558,0,0,5
179,Rett syndrome causing genes WP4312,0.5424891012272451,1.0330857528696826,0.631822109398869,"['MECP2', 'GNAO1', 'HDAC5', 'GABRA3', 'CRK']",0.9999063297382558,0,0,5
180,Synaptic Vesicle Pathway WP2267,0.5424891012272451,1.0330857528696826,0.631822109398869,"['NAPA', 'CLTC', 'PARK7', 'STX3', 'AP2A2']",0.9999063297382558,0,0,5
181,GABA receptor Signaling WP4159,0.5490626277058926,1.0661631827376938,0.6392104257307819,"['GABRA6', 'GABRA3', 'AP2A2']",0.9999063297382558,0,0,3
182,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5490626277058926,1.0661631827376938,0.6392104257307819,"['EIF2AK2', 'FOS', 'IRF9']",0.9999063297382558,0,0,3
183,Peptide GPCRs WP24,0.5490626277058926,1.0661631827376938,0.6392104257307819,"['EDNRA', 'CCKBR', 'SSTR2']",0.9999063297382558,0,0,3
184,The influence of laminopathies on Wnt signaling WP4844,0.5490626277058926,1.0661631827376938,0.6392104257307819,"['CEBPD', 'FNTA', 'TOR1AIP1']",0.9999063297382558,0,0,3
185,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.5565012935429651,1.110596361185984,0.6509047388793439,"['ACOX3', 'PLA2G6']",0.9999063297382558,0,0,2
186,Purine metabolism and related disorders WP4224,0.5565012935429651,1.110596361185984,0.6509047388793439,"['DGUOK', 'ATIC']",0.9999063297382558,0,0,2
187,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.5565012935429651,1.110596361185984,0.6509047388793439,"['IDH2', 'SDHC']",0.9999063297382558,0,0,2
188,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.5565012935429651,1.110596361185984,0.6509047388793439,"['EIF2AK2', 'IRF9']",0.9999063297382558,0,0,2
189,Interferon type I signaling pathways WP585,0.5614082309957616,1.009529801731017,0.5828085744148305,"['EIF4A1', 'EIF4EBP1', 'PTPN11', 'CRK', 'IRF9']",0.9999063297382558,0,0,5
190,TNF-alpha signaling pathway WP231,0.5686159057877632,0.9869944369267779,0.5572078145397541,"['CASP9', 'CSNK2A1', 'TRAF2', 'GRB2', 'CFLAR', 'MAP2K7', 'PRKCZ', 'BIRC2']",0.9999063297382558,0,0,8
191,Autophagy WP4923,0.5735364833379577,1.0250791016131542,0.5698760476846638,"['BECN1', 'PRKAB2', 'ATG16L1']",0.9999063297382558,0,0,3
192,Melatonin metabolism and effects WP3298,0.5735364833379577,1.0250791016131542,0.5698760476846638,"['SULT1A1', 'CSNK1E', 'CALM2']",0.9999063297382558,0,0,3
193,PDGFR-beta pathway WP3972,0.5735364833379577,1.0250791016131542,0.5698760476846638,"['EIF2AK2', 'GRB2', 'FOS']",0.9999063297382558,0,0,3
194,Tumor suppressor activity of SMARCB1 WP4204,0.5735364833379577,1.0250791016131542,0.5698760476846638,"['SMARCD1', 'RBBP4', 'ARID1A']",0.9999063297382558,0,0,3
195,Autosomal recessive Osteopetrosis pathways WP4788,0.5741100835456522,1.2692640692640693,0.7043579366211874,['OSTM1'],0.9999063297382558,0,0,1
196,Cell Differentiation - Index WP2029,0.5741100835456522,1.2692640692640693,0.7043579366211874,['HDAC5'],0.9999063297382558,0,0,1
197,"Degradation pathway of sphingolipids, including diseases WP4153",0.5741100835456522,1.2692640692640693,0.7043579366211874,['HEXB'],0.9999063297382558,0,0,1
198,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.5741100835456522,1.2692640692640693,0.7043579366211874,['ADH5'],0.9999063297382558,0,0,1
199,Heme Biosynthesis WP561,0.5741100835456522,1.2692640692640693,0.7043579366211874,['FECH'],0.9999063297382558,0,0,1
200,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.5741100835456522,1.2692640692640693,0.7043579366211874,['BLVRB'],0.9999063297382558,0,0,1
201,Nephrogenesis WP5052,0.5741100835456522,1.2692640692640693,0.7043579366211874,['JAG1'],0.9999063297382558,0,0,1
202,Selective expression of chemokine receptors during T-cell polarization WP4494,0.5741100835456522,1.2692640692640693,0.7043579366211874,['IFNGR2'],0.9999063297382558,0,0,1
203,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.5741100835456522,1.2692640692640693,0.7043579366211874,['RASGRF1'],0.9999063297382558,0,0,1
204,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5865750041771723,1.0451878864753448,0.5575604266966468,"['UGCG', 'KDSR']",0.9999063297382558,0,0,2
205,NAD+ biosynthetic pathways WP3645,0.5865750041771723,1.0451878864753448,0.5575604266966468,"['PARP1', 'SIRT6']",0.9999063297382558,0,0,2
206,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.5865750041771723,1.0451878864753448,0.5575604266966468,"['ABCC4', 'FOS']",0.9999063297382558,0,0,2
207,Joubert Syndrome WP4656,0.5868897813967419,0.9715073529411765,0.5177339913172907,"['TMEM17', 'PARP1', 'TCTN3', 'TMEM138', 'TCTN1', 'BBS4', 'RHOA']",0.9999063297382558,0,0,7
208,Endometrial cancer WP4155,0.5916818796180464,0.968992628992629,0.5085139150629044,"['CASP9', 'CDH1', 'GRB2', 'FOS', 'FGF1', 'FGFR1']",0.9999063297382558,0,0,6
209,CAMKK2  Pathway WP4874,0.5971636970331559,0.987038285757099,0.508881410498746,"['NOS1', 'CALM2', 'CAMKK2']",0.9999063297382558,0,0,3
210,Androgen receptor signaling pathway WP138,0.597424340662931,0.9601726218776286,0.49461144681050245,"['PSMC3IP', 'UBE2I', 'ZMIZ1', 'KAT7', 'STUB1', 'PARK7', 'PATZ1', 'RHOA']",0.9999063297382558,0,0,8
211,G1 to S cell cycle control WP45,0.5980149883096759,0.965490414819599,0.49639672174886307,"['ORC6', 'CCNE2', 'ORC3', 'RPA1', 'RPA2']",0.9999063297382558,0,0,5
212,IL-1 signaling pathway WP195,0.5980149883096759,0.965490414819599,0.49639672174886307,"['UBE2N', 'PTPN11', 'UBE2V1', 'MAP2K7', 'PRKCZ']",0.9999063297382558,0,0,5
213,Notch Signaling Pathway Netpath WP61,0.5980149883096759,0.965490414819599,0.49639672174886307,"['NUMBL', 'JAG1', 'CIR1', 'MAPT', 'DLL1']",0.9999063297382558,0,0,5
214,Retinoblastoma gene in cancer WP2446,0.6020745852953788,0.9564882717012535,0.485297228245453,"['RRM1', 'RABIF', 'CCNE2', 'RBBP4', 'PRKDC', 'RPA1', 'RPA2']",0.9999063297382558,0,0,7
215,Histone Modifications WP2369,0.6068002268682995,0.960280118174855,0.4797133659450686,"['SETD9', 'EHMT2', 'SMYD2', 'KMT5B']",0.9999063297382558,0,0,4
216,Canonical and non-canonical Notch signaling WP3845,0.615107803004435,0.987047020065888,0.47966313628144325,"['JAG1', 'DLL1']",0.9999063297382558,0,0,2
217,Urea cycle and associated pathways WP4595,0.615107803004435,0.987047020065888,0.47966313628144325,"['GOT2', 'NOS1']",0.9999063297382558,0,0,2
218,Biotin Metabolism (including IEMs) WP5031,0.6172241019941148,1.1105218855218855,0.5358524724972242,['PCCB'],0.9999063297382558,0,0,1
219,Cytokines and Inflammatory Response WP530,0.6172241019941148,1.1105218855218855,0.5358524724972242,['PDGFA'],0.9999063297382558,0,0,1
220,Osteoclast Signaling WP12,0.6172241019941148,1.1105218855218855,0.5358524724972242,['AIMP2'],0.9999063297382558,0,0,1
221,miRNA regulation of prostate cancer signaling pathways WP3981,0.6199172006169951,0.9517146710336191,0.45508079253657696,"['CASP9', 'PDGFA', 'GRB2']",0.9999063297382558,0,0,3
222,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.6199172006169951,0.9517146710336191,0.45508079253657696,"['PDHA1', 'SLC16A1', 'SLC2A3']",0.9999063297382558,0,0,3
223,Neural Crest Differentiation WP2064,0.6238715547451439,0.934850640113798,0.4410726036710465,"['HDAC5', 'CDH1', 'MPZ', 'WNT8A', 'DLL1', 'FGFR1']",0.9999063297382558,0,0,6
224,"GPCRs, Other WP117",0.6262216221991141,0.9349385609773422,0.4375988736759526,"['EDNRA', 'CCKBR', 'GPR61', 'SSTR2']",0.9999063297382558,0,0,4
225,Mitochondrial CIV Assembly WP4922,0.6417787621374421,0.9188271676703792,0.40751054579758134,"['SURF1', 'COX15', 'SMIM20']",0.9999063297382558,0,0,3
226,NRF2-ARE regulation WP4357,0.6421034470689234,0.9350262448574266,0.41422210176721297,"['AIMP2', 'RBX1']",0.9999063297382558,0,0,2
227,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.6421034470689234,0.9350262448574266,0.41422210176721297,"['OMG', 'IGF1']",0.9999063297382558,0,0,2
228,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6495394423849387,0.9061720569389133,0.3910057371173299,"['ACTR2', 'PFN4', 'GRB2', 'NOS1', 'RHOA']",0.9999063297382558,0,0,5
229,Cancer immunotherapy by CTLA4 blockade WP4582,0.6559761920846293,0.9870557426112981,0.41617308586916224,['PTPN11'],0.9999063297382558,0,0,1
230,Dopamine metabolism WP2436,0.6559761920846293,0.9870557426112981,0.41617308586916224,['PPP2CB'],0.9999063297382558,0,0,1
231,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.6559761920846293,0.9870557426112981,0.41617308586916224,['MAFF'],0.9999063297382558,0,0,1
232,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.6559761920846293,0.9870557426112981,0.41617308586916224,['GRM4'],0.9999063297382558,0,0,1
233,miR-509-3p alteration of YAP1/ECM axis WP3967,0.6559761920846293,0.9870557426112981,0.41617308586916224,['EDNRA'],0.9999063297382558,0,0,1
234,Nanoparticle triggered regulated necrosis WP2513,0.6559761920846293,0.9870557426112981,0.41617308586916224,['PARP1'],0.9999063297382558,0,0,1
235,TCA cycle in senescence WP5050,0.6559761920846293,0.9870557426112981,0.41617308586916224,['PDHA1'],0.9999063297382558,0,0,1
236,Transcriptional cascade regulating adipogenesis WP4211,0.6559761920846293,0.9870557426112981,0.41617308586916224,['CEBPD'],0.9999063297382558,0,0,1
237,Amyotrophic lateral sclerosis (ALS) WP2447,0.662738013645161,0.8881321645313554,0.365355830802151,"['CASP9', 'TOMM40', 'NOS1']",0.9999063297382558,0,0,3
238,Disruption of postsynaptic signaling by CNV WP4875,0.662738013645161,0.8881321645313554,0.365355830802151,"['RPH3A', 'ARC', 'HOMER1']",0.9999063297382558,0,0,3
239,p38 MAPK Signaling Pathway WP400,0.662738013645161,0.8881321645313554,0.365355830802151,"['RASGRF1', 'TRAF2', 'GRB2']",0.9999063297382558,0,0,3
240,Nonalcoholic fatty liver disease WP4396,0.6641098927163946,0.9104129701144626,0.37263898615355234,"['ERN1', 'NDUFA9', 'PRKAB2', 'NDUFB8', 'NDUFB6', 'NDUFAB1', 'SDHC', 'TRAF2', 'NDUFS1', 'UQCRC2', 'NDUFV3', 'EIF2S1']",0.9999063297382558,0,0,12
241,Oncostatin M Signaling Pathway WP2374,0.665751398468842,0.8879810938555031,0.3612652991284224,"['EGR1', 'PTPN11', 'GRB2', 'FOS', 'JUNB']",0.9999063297382558,0,0,5
242,1q21.1 copy number variation syndrome WP4905,0.667580698826611,0.8882075471698113,0.3589202277936094,"['BCL9', 'PRKAB2']",0.9999063297382558,0,0,2
243,SARS-CoV-2 mitochondrial interactions WP5038,0.667580698826611,0.8882075471698113,0.3589202277936094,"['NLRX1', 'ACAD9']",0.9999063297382558,0,0,2
244,Sphingolipid Metabolism (general overview) WP4725,0.667580698826611,0.8882075471698113,0.3589202277936094,"['UGCG', 'KDSR']",0.9999063297382558,0,0,2
245,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.667580698826611,0.8882075471698113,0.3589202277936094,"['BCL9', 'PML']",0.9999063297382558,0,0,2
246,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6807037976835206,0.8663309305157829,0.3332151499997204,"['EIF4A1', 'CSNK2A1', 'EIF4EBP1', 'MAP2K7']",0.9999063297382558,0,0,4
247,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6827915302203863,0.8594174841754944,0.32792422759896145,"['FOS', 'MAP2K7', 'JUNB']",0.9999063297382558,0,0,3
248,16p11.2 proximal deletion syndrome WP4949,0.6836425663974118,0.8732831191847585,0.3321270897612526,"['PPP2CB', 'PRRT2', 'KCTD13', 'TRAF2', 'PPP2R5D', 'CCT8']",0.9999063297382558,0,0,6
249,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.6836425663974118,0.8732831191847585,0.3321270897612526,"['CASP9', 'RALB', 'MSH2', 'FOS', 'RALGDS', 'RHOA']",0.9999063297382558,0,0,6
250,7q11.23 copy number variation syndrome WP4932,0.6899536121854419,0.8767269750580531,0.3253804821505237,"['BECN1', 'MYBBP1A', 'CLTC', 'GRB2', 'BUD23', 'DEK', 'SF3B1', 'EIF2A']",0.9999063297382558,0,0,8
251,Development and heterogeneity of the ILC family WP3893,0.6908073907073501,0.8882828282828282,0.32857069634404146,['ID2'],0.9999063297382558,0,0,1
252,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.6908073907073501,0.8882828282828282,0.32857069634404146,['FAM20C'],0.9999063297382558,0,0,1
253,Glutathione metabolism WP100,0.6908073907073501,0.8882828282828282,0.32857069634404146,['GSS'],0.9999063297382558,0,0,1
254,Homologous recombination WP186,0.6908073907073501,0.8882828282828282,0.32857069634404146,['RPA1'],0.9999063297382558,0,0,1
255,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.6908073907073501,0.8882828282828282,0.32857069634404146,['CDH1'],0.9999063297382558,0,0,1
256,"NAD metabolism, sirtuins and aging WP3630",0.6908073907073501,0.8882828282828282,0.32857069634404146,['PARP1'],0.9999063297382558,0,0,1
257,Neuroinflammation WP4919,0.6908073907073501,0.8882828282828282,0.32857069634404146,['FOS'],0.9999063297382558,0,0,1
258,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.6908073907073501,0.8882828282828282,0.32857069634404146,['SAMHD1'],0.9999063297382558,0,0,1
259,Sphingolipid Metabolism (integrated pathway) WP4726,0.6915702549647537,0.8458477730714927,0.31194065285568173,"['UGCG', 'KDSR']",0.9999063297382558,0,0,2
260,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.7008403450459166,0.9042546141356572,0.3214400636158341,"['RAB2A', 'FLT1', 'LPAR1', 'PDGFA', 'SLC2A3', 'PPP2R5D', 'IGF1', 'FGF1', 'ELAVL1', 'GYS2', 'CASP9', 'PPP2CB', 'RELN', 'PPP2R3C', 'EIF4EBP1', 'GNB4', 'GRB2', 'NOS1', 'EIF4E2', 'FGF22', 'FGFR1']",0.9999063297382558,0,0,21
261,Netrin-UNC5B signaling pathway WP4747,0.7019419662004897,0.8324974713418746,0.2946246409764593,"['NTN4', 'PTPN11', 'RHOA']",0.9999063297382558,0,0,3
262,ESC Pluripotency Pathways WP3931,0.7137562022511876,0.8554705968664916,0.2884765150365214,"['ACTR2', 'PDGFA', 'GRB2', 'PTPN11', 'FOS', 'FGF1', 'FGF22', 'FGFR1']",0.9999063297382558,0,0,8
263,Endochondral Ossification with Skeletal Dysplasias WP4808,0.7137964799286395,0.8259109311740891,0.27846198168369257,"['ADAMTS5', 'IGF1', 'CALM2', 'FGFR1']",0.9999063297382558,0,0,4
264,Endochondral Ossification WP474,0.7137964799286395,0.8259109311740891,0.27846198168369257,"['ADAMTS5', 'IGF1', 'CALM2', 'FGFR1']",0.9999063297382558,0,0,4
265,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.7137964799286395,0.8259109311740891,0.27846198168369257,"['PRKAB2', 'ARC', 'HOMER1', 'EIF4EBP1']",0.9999063297382558,0,0,4
266,Ferroptosis WP4313,0.7201972511203872,0.8072089744375651,0.2649503184042935,"['FTH1', 'GSS', 'LPCAT3']",0.9999063297382558,0,0,3
267,G13 Signaling Pathway WP524,0.7201972511203872,0.8072089744375651,0.2649503184042935,"['CALM2', 'RHOA', 'CIT']",0.9999063297382558,0,0,3
268,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7201972511203872,0.8072089744375651,0.2649503184042935,"['CASP9', 'PTPN11', 'GRB2']",0.9999063297382558,0,0,3
269,Notch Signaling WP268,0.7201972511203872,0.8072089744375651,0.2649503184042935,"['NUMBL', 'JAG1', 'DLL1']",0.9999063297382558,0,0,3
270,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.7221141684509602,0.8074686256504439,0.2628891952070091,['CCKBR'],0.9999063297382558,0,0,1
271,FOXA2 pathway WP5066,0.7221141684509602,0.8074686256504439,0.2628891952070091,['ABCC4'],0.9999063297382558,0,0,1
272,Galanin receptor pathway WP4970,0.7221141684509602,0.8074686256504439,0.2628891952070091,['FOS'],0.9999063297382558,0,0,1
273,Genes targeted by miRNAs in adipocytes WP1992,0.7221141684509602,0.8074686256504439,0.2628891952070091,['IGF1'],0.9999063297382558,0,0,1
274,Hedgehog Signaling Pathway Netpath WP47,0.7221141684509602,0.8074686256504439,0.2628891952070091,['KIF7'],0.9999063297382558,0,0,1
275,ID signaling pathway WP53,0.7221141684509602,0.8074686256504439,0.2628891952070091,['ID2'],0.9999063297382558,0,0,1
276,NO metabolism in cystic fibrosis WP4947,0.7221141684509602,0.8074686256504439,0.2628891952070091,['NOS1'],0.9999063297382558,0,0,1
277,Leptin signaling pathway WP2034,0.7241773660166254,0.8321579391891892,0.2685531246469749,"['KHDRBS1', 'EIF4EBP1', 'PTPN11', 'GRB2', 'RHOA', 'SH2B1']",0.9999063297382558,0,0,6
278,AMP-activated protein kinase (AMPK) signaling WP1403,0.7255686681703933,0.8219546352564584,0.26368268672308703,"['GYS2', 'PRKAB2', 'EIF4EBP1', 'ELAVL1', 'CAMKK2']",0.9999063297382558,0,0,5
279,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.7287427502292944,0.8532025224098395,0.2699827046993288,"['JAG1', 'RBBP4', 'CDH1', 'CTDSP1', 'PDCD6', 'ID2', 'CLDN12', 'WNT8A', 'GRB2', 'DLL1']",0.9999063297382558,0,0,10
280,G Protein Signaling Pathways WP35,0.736063402182385,0.8283254451205769,0.25383123739027996,"['GNAO1', 'PDE1C', 'PDE4B', 'ADCY3', 'PRKCZ', 'CALM2', 'RHOA']",0.9999063297382558,0,0,7
281,Nephrotic syndrome WP4758,0.7375698464271963,0.7834080361746857,0.23846508824874801,"['SCARB2', 'YARS', 'WDR73']",0.9999063297382558,0,0,3
282,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7375698464271963,0.7834080361746857,0.23846508824874801,"['LARP1', 'TRIM25', 'TRAF2']",0.9999063297382558,0,0,3
283,Calcium Regulation in the Cardiac Cell WP536,0.7405186261690871,0.8486131171702285,0.2549271924422884,"['GNAO1', 'YWHAE', 'RGS17', 'KCNB1', 'GNB4', 'ATP2A2', 'ADCY3', 'ATP2B3', 'PRKCZ', 'CALM2', 'YWHAH']",0.9999063297382558,0,0,11
284,Ras signaling WP4223,0.7447696978697422,0.8541801815393125,0.2517100198480996,"['RAB5B', 'FLT1', 'RALB', 'RASGRF1', 'PTPN11', 'PLA2G6', 'RHOA', 'RASSF1', 'GNB4', 'GRB2', 'RALGDS', 'CALM2', 'FGFR1']",0.9999063297382558,0,0,13
285,Thermogenesis WP4321,0.7471341898189937,0.8254397834912043,0.2406243406210696,"['SMARCD1', 'PRKAB2', 'PRKG2', 'ADCY3', 'GRB2', 'SIRT6', 'ARID1A', 'FGFR1']",0.9999063297382558,0,0,8
286,Major receptors targeted by epinephrine and norepinephrine WP4589,0.7502529300419499,0.7401234567901235,0.21267069272157035,['ADCY3'],0.9999063297382558,0,0,1
287,Matrix Metalloproteinases WP129,0.7502529300419499,0.7401234567901235,0.21267069272157035,['MMP28'],0.9999063297382558,0,0,1
288,Omega-9 FA synthesis WP4724,0.7502529300419499,0.7401234567901235,0.21267069272157035,['ACOT2'],0.9999063297382558,0,0,1
289,Phytochemical activity on NRF2 transcriptional activation WP3,0.7502529300419499,0.7401234567901235,0.21267069272157035,['AIMP2'],0.9999063297382558,0,0,1
290,Tryptophan catabolism leading to NAD+ production WP4210,0.7502529300419499,0.7401234567901235,0.21267069272157035,['KMO'],0.9999063297382558,0,0,1
291,Allograft Rejection WP2328,0.7540760631139583,0.7609671515268278,0.21479213797618724,"['CASP9', 'HLA-C', 'PRKCZ']",0.9999063297382558,0,0,3
292,IL-6 signaling pathway WP364,0.7540760631139583,0.7609671515268278,0.21479213797618724,"['PTPN11', 'GRB2', 'JUNB']",0.9999063297382558,0,0,3
293,Ethanol effects on histone modifications WP3996,0.7550468202750583,0.7399483378256964,0.20790736754824232,"['HDAC5', 'EHMT2']",0.9999063297382558,0,0,2
294,Glycerophospholipid Biosynthetic Pathway WP2533,0.7550468202750583,0.7399483378256964,0.20790736754824232,"['PGS1', 'PTPMT1']",0.9999063297382558,0,0,2
295,Lipid Metabolism Pathway WP3965,0.7550468202750583,0.7399483378256964,0.20790736754824232,"['PRKAB2', 'PDHA1']",0.9999063297382558,0,0,2
296,Tryptophan metabolism WP465,0.7550468202750583,0.7399483378256964,0.20790736754824232,"['ALDH3A2', 'GCDH']",0.9999063297382558,0,0,2
297,NRF2 pathway WP2884,0.7576343961876324,0.8158897547166877,0.22645373963038892,"['EGR1', 'ABCC4', 'SLC39A9', 'FTH1', 'TXNRD1', 'MAFF', 'BLVRB', 'SLC2A3']",0.9999063297382558,0,0,8
298,Breast cancer pathway WP4262,0.7579484786592218,0.8290910011903857,0.2297741687697472,"['CSNK2A1', 'PARP1', 'CETN3', 'GRB2', 'IGF1', 'FOS', 'FGF1', 'DLL1', 'FGF22', 'FGFR1']",0.9999063297382558,0,0,10
299,Cardiac Hypertrophic Response WP2795,0.7585932270526241,0.7718711494455202,0.21325995414047244,"['HDAC5', 'IGF1', 'MAP2K7', 'CALM2']",0.9999063297382558,0,0,4
300,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.7585932270526241,0.7718711494455202,0.21325995414047244,"['NLRX1', 'TKFC', 'TRIM25', 'TRAF2']",0.9999063297382558,0,0,4
301,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.7651000587109081,0.7785161756518237,0.20844666126835815,"['CSNK2A1', 'CTNNBIP1', 'CSNK1E', 'SENP2', 'ELAVL1']",0.9999063297382558,0,0,5
302,Metabolic reprogramming in colon cancer WP4290,0.7697354392622665,0.7397729826927399,0.19360480998663285,"['PDHA1', 'GOT2', 'IDH2']",0.9999063297382558,0,0,3
303,Complement and Coagulation Cascades WP558,0.773548215222678,0.7102964959568733,0.18238089718276101,"['CLTC', 'SERPING1']",0.9999063297382558,0,0,2
304,Oxidation by Cytochrome P450 WP43,0.773548215222678,0.7102964959568733,0.18238089718276101,"['CYP4Z1', 'CYP20A1']",0.9999063297382558,0,0,2
305,ERK Pathway in Huntington's Disease WP3853,0.775544060962435,0.6831390831390831,0.1736474526661307,['MAP2K7'],0.9999063297382558,0,0,1
306,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.775544060962435,0.6831390831390831,0.1736474526661307,['IGF1'],0.9999063297382558,0,0,1
307,Hypertrophy Model WP516,0.775544060962435,0.6831390831390831,0.1736474526661307,['EIF4EBP1'],0.9999063297382558,0,0,1
308,IL-9 signaling pathway WP22,0.775544060962435,0.6831390831390831,0.1736474526661307,['GRB2'],0.9999063297382558,0,0,1
309,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.775544060962435,0.6831390831390831,0.1736474526661307,['CDH1'],0.9999063297382558,0,0,1
310,Circadian rhythm related genes WP3594,0.7777265934537081,0.82934548491553,0.2084810660980463,"['EGR1', 'DDX5', 'EGR3', 'HOMER1', 'PRKDC', 'CSNK1E', 'PML', 'SETX', 'MYBBP1A', 'THRAP3', 'ID2', 'KLF9', 'PRKG2']",0.9999063297382558,0,0,13
311,IL-3 signaling pathway WP286,0.7845701749502072,0.7197244446064406,0.17461901142950353,"['PTPN11', 'GRB2', 'FOS']",0.9999063297382558,0,0,3
312,One-carbon metabolism and related pathways WP3940,0.7845701749502072,0.7197244446064406,0.17461901142950353,"['DMGDH', 'GSS', 'BCAT1']",0.9999063297382558,0,0,3
313,Osteoblast differentiation WP4787,0.7898747666525194,0.7762592968221771,0.1831047177458308,"['JAG1', 'PRKDC', 'WNT8A', 'FGF1', 'PRKCZ', 'DLL1', 'FGFR1']",0.9999063297382558,0,0,7
314,Vitamin D Receptor Pathway WP2877,0.7898747666525194,0.7762592968221771,0.1831047177458308,"['ADAMTS5', 'CEACAM1', 'TPM1', 'MED9', 'GXYLT2', 'CLPTM1L', 'JUNB']",0.9999063297382558,0,0,7
315,Neural Crest Cell Migration during Development WP4564,0.7908163105488856,0.6829255650010367,0.16027550208410532,"['FOS', 'RHOA']",0.9999063297382558,0,0,2
316,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.7908163105488856,0.6829255650010367,0.16027550208410532,"['CASP9', 'NOS1']",0.9999063297382558,0,0,2
317,Zinc homeostasis WP3529,0.7908163105488856,0.6829255650010367,0.16027550208410532,"['SLC30A9', 'SLC39A9']",0.9999063297382558,0,0,2
318,Canonical and non-canonical TGF-B signaling WP3874,0.7982755652211049,0.6342953342953342,0.14290764035056136,['LOXL2'],0.9999063297382558,0,0,1
319,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.7982755652211049,0.6342953342953342,0.14290764035056136,['ACOX3'],0.9999063297382558,0,0,1
320,Eicosanoid Synthesis WP167,0.7982755652211049,0.6342953342953342,0.14290764035056136,['PLA2G6'],0.9999063297382558,0,0,1
321,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.7982755652211049,0.6342953342953342,0.14290764035056136,['RHOA'],0.9999063297382558,0,0,1
322,MAPK pathway in congenital thyroid cancer WP4928,0.7982755652211049,0.6342953342953342,0.14290764035056136,['FOS'],0.9999063297382558,0,0,1
323,Mitochondrial complex III assembly WP4921,0.7982755652211049,0.6342953342953342,0.14290764035056136,['UQCRC2'],0.9999063297382558,0,0,1
324,SARS coronavirus and innate immunity WP4912,0.7982755652211049,0.6342953342953342,0.14290764035056136,['IRF9'],0.9999063297382558,0,0,1
325,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.7982755652211049,0.6342953342953342,0.14290764035056136,['PDHA1'],0.9999063297382558,0,0,1
326,Nuclear receptors WP170,0.806911085481008,0.6575821104122991,0.14107884689597508,"['NR4A1', 'NR1H2']",0.9999063297382558,0,0,2
327,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8159435688655021,0.7864789502460361,0.15997774792714745,"['EGR1', 'MARCKS', 'CSNK2A1', 'RASGRF1', 'EIF4EBP1', 'GRB2', 'PTPN11', 'FOS', 'MAPT', 'EIF2S1', 'SH2B1']",0.9999063297382558,0,0,11
328,Globo Sphingolipid Metabolism WP1424,0.8187063363409132,0.5919640852974186,0.11841047127230116,['ST6GALNAC4'],0.9999063297382558,0,0,1
329,Glycosaminoglycan degradation WP4815,0.8187063363409132,0.5919640852974186,0.11841047127230116,['HEXB'],0.9999063297382558,0,0,1
330,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.8187063363409132,0.5919640852974186,0.11841047127230116,['ACADS'],0.9999063297382558,0,0,1
331,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.8187063363409132,0.5919640852974186,0.11841047127230116,['SIRT6'],0.9999063297382558,0,0,1
332,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.8187063363409132,0.5919640852974186,0.11841047127230116,['NLRX1'],0.9999063297382558,0,0,1
333,Transcription factor regulation in adipogenesis WP3599,0.8187063363409132,0.5919640852974186,0.11841047127230116,['CEBPD'],0.9999063297382558,0,0,1
334,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8243781395797768,0.6655933917734322,0.12854335415735635,"['ADCY3', 'GRB2', 'RHOA']",0.9999063297382558,0,0,3
335,TGF-beta Signaling Pathway WP366,0.8272607717859146,0.7599961311538833,0.14412210274134826,"['UBE2I', 'SNIP1', 'FOSB', 'GRB2', 'FOS', 'JUNB', 'RHOA', 'PML', 'RBX1']",0.9999063297382558,0,0,9
336,PI3K-Akt signaling pathway WP4172,0.8291864234334899,0.8201328886867768,0.15361931416483113,"['FLT1', 'LPAR1', 'PDGFA', 'PPP2R5D', 'IGF1', 'FGF1', 'GYS2', 'CASP9', 'PPP2CB', 'RELN', 'CCNE2', 'PPP2R3C', 'EIF4EBP1', 'GNB4', 'GRB2', 'SGK3', 'EIF4E2', 'SGK2', 'FGF22', 'FGFR1']",0.9999063297382558,0,0,20
337,Apoptosis Modulation and Signaling WP1772,0.8309540723781523,0.7040502449010214,0.13037655488807415,"['CASP9', 'DFFA', 'FOS', 'CFLAR', 'BIRC2']",0.9999063297382558,0,0,5
338,Wnt signaling pathway and pluripotency WP399,0.83237563363549,0.7191563184806428,0.13194465778794753,"['PPP2CB', 'CSNK1E', 'PRKCZ', 'FBXW2', 'RHOA', 'PAFAH1B1']",0.9999063297382558,0,0,6
339,MAPK Cascade WP422,0.8358223534829613,0.612138674598011,0.10978045058802327,"['GRB2', 'MAP2K7']",0.9999063297382558,0,0,2
340,Neural Crest Cell Migration in Cancer WP4565,0.8358223534829613,0.612138674598011,0.10978045058802327,"['FOS', 'RHOA']",0.9999063297382558,0,0,2
341,IL-4 signaling pathway WP395,0.836172809912178,0.6493100669374866,0.11617454213702187,"['PTPN11', 'GRB2', 'FOS']",0.9999063297382558,0,0,3
342,Nucleotide Excision Repair WP4753,0.836172809912178,0.6493100669374866,0.11617454213702187,"['RPA1', 'RPA2', 'RBX1']",0.9999063297382558,0,0,3
343,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.8370690981465524,0.5549242424242424,0.09869253145399458,['EIF4EBP1'],0.9999063297382558,0,0,1
344,Apoptosis Modulation by HSP70 WP384,0.8370690981465524,0.5549242424242424,0.09869253145399458,['CASP9'],0.9999063297382558,0,0,1
345,Imatinib and Chronic Myeloid Leukemia WP3640,0.8370690981465524,0.5549242424242424,0.09869253145399458,['FLT1'],0.9999063297382558,0,0,1
346,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.8403188932386538,0.6929967083051992,0.1205632876265496,"['HNRNPK', 'CSNK2A1', 'CTNNBIP1', 'CSNK1E', 'SENP2']",0.9999063297382558,0,0,5
347,Energy Metabolism WP1541,0.8472777172274443,0.6338021385223004,0.1050379715307787,"['PRKAB2', 'MYBBP1A', 'TFB2M']",0.9999063297382558,0,0,3
348,RANKL/RANK signaling pathway WP2018,0.8472777172274443,0.6338021385223004,0.1050379715307787,"['TRAF2', 'FOS', 'MAP2K7']",0.9999063297382558,0,0,3
349,Fatty acid beta-oxidation WP143,0.848758565316331,0.5916891284815813,0.09702548414854432,"['GCDH', 'ACADS']",0.9999063297382558,0,0,2
350,Prostaglandin Synthesis and Regulation WP98,0.848758565316331,0.5916891284815813,0.09702548414854432,"['ABCC4', 'EDNRA']",0.9999063297382558,0,0,2
351,Pathways Regulating Hippo Signaling WP4540,0.8493140169429438,0.700124466571835,0.11434873461767454,"['PRKAB2', 'FLT1', 'CDH1', 'PRKCZ', 'RHOA', 'FGFR1']",0.9999063297382558,0,0,6
352,IL-18 signaling pathway WP4754,0.8505775108484679,0.7816411404806655,0.12650059556772003,"['MBTPS1', 'TOMM40', 'ANP32A', 'PARP1', 'HSPB8', 'ECH1', 'FOS', 'DEK', 'CFLAR', 'ELAVL1', 'NR4A1', 'ADAMTS5', 'CLDN12', 'MAP2K7', 'ACADS']",0.9999063297382558,0,0,15
353,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.8514683832748592,0.6571200079972009,0.10566023843083253,"['SGCB', 'DAG1', 'ATP2A2', 'CACNG3']",0.9999063297382558,0,0,4
354,Hippo-Yap signaling pathway WP4537,0.8535730479585211,0.522242028124381,0.08268352731196064,['RASSF1'],0.9999063297382558,0,0,1
355,Methionine De Novo and Salvage Pathway WP3580,0.8535730479585211,0.522242028124381,0.08268352731196064,['SMS'],0.9999063297382558,0,0,1
356,Nucleotide metabolism WP404,0.8535730479585211,0.522242028124381,0.08268352731196064,['RRM1'],0.9999063297382558,0,0,1
357,Purinergic signaling WP4900,0.8535730479585211,0.522242028124381,0.08268352731196064,['GNAO1'],0.9999063297382558,0,0,1
358,Vitamin D in inflammatory diseases WP4482,0.8535730479585211,0.522242028124381,0.08268352731196064,['DUSP1'],0.9999063297382558,0,0,1
359,MAPK Signaling Pathway WP382,0.8548480005074925,0.7882628421941771,0.12362452515331798,"['DUSP1', 'RASGRF1', 'PDGFA', 'TRAF2', 'FOS', 'FGF1', 'DUSP16', 'NR4A1', 'GRB2', 'MAPT', 'MAP2K7', 'MAP3K13', 'CRK', 'CACNG3', 'PTPN5', 'FGF22', 'FGFR1']",0.9999063297382558,0,0,17
360,Exercise-induced Circadian Regulation WP410,0.8577220667656424,0.6190155091031693,0.09500350645619879,"['PPP2CB', 'PSMA4', 'KLF9']",0.9999063297382558,0,0,3
361,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.860624707356526,0.6451232977548768,0.0968309100424784,"['SCARB2', 'JAG1', 'MME', 'DAG1']",0.9999063297382558,0,0,4
362,Oxidative Damage WP3941,0.8607598635504613,0.5725589079210504,0.0858493209504339,"['CASP9', 'TRAF2']",0.9999063297382558,0,0,2
363,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8607598635504613,0.5725589079210504,0.0858493209504339,"['EIF4EBP1', 'PTPN11']",0.9999063297382558,0,0,2
364,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8607598635504613,0.5725589079210504,0.0858493209504339,"['TRAF2', 'BIRC2']",0.9999063297382558,0,0,2
365,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8658775607591318,0.6618158364154918,0.0953092668528604,"['HDAC5', 'IGF1', 'MAP2K7', 'CALM2', 'RHOA']",0.9999063297382558,0,0,5
366,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.8684062339003763,0.49319117096894877,0.06958713495720387,['H2AFY'],0.9999063297382558,0,0,1
367,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.8684062339003763,0.49319117096894877,0.06958713495720387,['TERF2'],0.9999063297382558,0,0,1
368,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.8684062339003763,0.49319117096894877,0.06958713495720387,['PDHA1'],0.9999063297382558,0,0,1
369,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.8684062339003763,0.49319117096894877,0.06958713495720387,['CASP9'],0.9999063297382558,0,0,1
370,Mitochondrial Gene Expression WP391,0.8684062339003763,0.49319117096894877,0.06958713495720387,['TFB2M'],0.9999063297382558,0,0,1
371,Ovarian infertility WP34,0.8684062339003763,0.49319117096894877,0.06958713495720387,['EGR1'],0.9999063297382558,0,0,1
372,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.8684062339003763,0.49319117096894877,0.06958713495720387,['RASGRF1'],0.9999063297382558,0,0,1
373,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.8684062339003763,0.49319117096894877,0.06958713495720387,['EGR1'],0.9999063297382558,0,0,1
374,Triacylglyceride synthesis WP325,0.8684062339003763,0.49319117096894877,0.06958713495720387,['AGPAT5'],0.9999063297382558,0,0,1
375,Bladder cancer WP2828,0.8718828566815274,0.5546243261455526,0.07603910757316619,"['RASSF1', 'CDH1']",0.9999063297382558,0,0,2
376,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.8767461498819022,0.5914138008541245,0.07779325920860115,"['ERN1', 'TNFRSF21', 'HSPD1']",0.9999063297382558,0,0,3
377,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.8767461498819022,0.5914138008541245,0.07779325920860115,"['FNTA', 'CEBPD', 'JUNB']",0.9999063297382558,0,0,3
378,Wnt Signaling Pathway WP363,0.8767461498819022,0.5914138008541245,0.07779325920860115,"['BCL9', 'CSNK1E', 'RHOA']",0.9999063297382558,0,0,3
379,Cell cycle WP179,0.8785797099205548,0.6818536433140896,0.08826502773029013,"['YWHAE', 'ORC6', 'CCNE2', 'PRKDC', 'ORC3', 'RBX1', 'YWHAH']",0.9999063297382558,0,0,7
380,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.8817376916967529,0.46719829877724617,0.05880189039882296,['EIF4EBP1'],0.9999063297382558,0,0,1
381,miRNA regulation of p53 pathway in prostate cancer WP3982,0.8817376916967529,0.46719829877724617,0.05880189039882296,['CASP9'],0.9999063297382558,0,0,1
382,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8817376916967529,0.46719829877724617,0.05880189039882296,['CALM2'],0.9999063297382558,0,0,1
383,Folate Metabolism WP176,0.891710780281271,0.5219200887902331,0.05981905486656412,"['MTHFD1', 'NOS1']",0.9999063297382558,0,0,2
384,Hedgehog Signaling Pathway WP4249,0.891710780281271,0.5219200887902331,0.05981905486656412,"['CSNK1E', 'KIF7']",0.9999063297382558,0,0,2
385,22q11.2 copy number variation syndrome WP4657,0.8918885572803246,0.6485992089650626,0.07420888826303675,"['XPO1', 'RELN', 'POLR2A', 'THAP7', 'RBX1', 'FGFR1']",0.9999063297382558,0,0,6
386,Melanoma WP4685,0.89256684934397,0.6012031382236556,0.06832906145608052,"['CDH1', 'GRB2', 'FOS', 'CALM2']",0.9999063297382558,0,0,4
387,Angiogenesis WP1539,0.8937193655905238,0.4438047138047138,0.04986743401678079,['FLT1'],0.9999063297382558,0,0,1
388,Heart Development WP1591,0.8937193655905238,0.4438047138047138,0.04986743401678079,['PTPN11'],0.9999063297382558,0,0,1
389,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.8937193655905238,0.4438047138047138,0.04986743401678079,['ENG'],0.9999063297382558,0,0,1
390,PKC-gamma calcium signaling pathway in ataxia WP4760,0.8937193655905238,0.4438047138047138,0.04986743401678079,['TRPC3'],0.9999063297382558,0,0,1
391,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9005188061726037,0.5069695802849442,0.053122417326223005,"['CDH1', 'LIMD1']",0.9999063297382558,0,0,2
392,EPO Receptor Signaling WP581,0.9044878354406398,0.422639089305756,0.04242722646707457,['GRB2'],0.9999063297382558,0,0,1
393,Estrogen signaling pathway WP712,0.9044878354406398,0.422639089305756,0.04242722646707457,['FOS'],0.9999063297382558,0,0,1
394,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.9044878354406398,0.422639089305756,0.04242722646707457,['MBTPS1'],0.9999063297382558,0,0,1
395,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9063569159634159,0.6623752734814665,0.06512613021920122,"['YWHAE', 'MECP2', 'EGR1', 'ADCYAP1R1', 'VIPR2', 'SSTR2', 'YWHAH', 'HSPD1']",0.9999063297382558,0,0,8
396,EGF/EGFR signaling pathway WP437,0.9076750733990622,0.6957433414043583,0.06739583170643962,"['RALB', 'IQSEC1', 'EIF4EBP1', 'FOSB', 'GRB2', 'PTPN11', 'FOS', 'PRKCZ', 'RALGDS', 'CRK', 'PTPN5']",0.9999063297382558,0,0,11
397,Integrated Cancer Pathway WP1971,0.9086544866924824,0.49284965558550464,0.04721024579173885,"['CASP9', 'MSH2']",0.9999063297382558,0,0,2
398,Interleukin-11 Signaling Pathway WP2332,0.9086544866924824,0.49284965558550464,0.04721024579173885,"['PTPN11', 'GRB2']",0.9999063297382558,0,0,2
399,T-cell receptor (TCR) signaling pathway WP69,0.9121220422399455,0.5719820643419964,0.05261175659148421,"['PTPN11', 'GRB2', 'FOS', 'CRK']",0.9999063297382558,0,0,4
400,VEGFA-VEGFR2 Signaling Pathway WP3888,0.9128147996989239,0.789237153015043,0.07199600233657673,"['NAPA', 'YWHAE', 'ARF4', 'HDAC5', 'FLT1', 'CLTC', 'SRP54', 'HTRA1', 'PRKCZ', 'CAMKK2', 'TUBB8', 'PSMD4', 'DHX36', 'MYH11', 'MAP2K7', 'EIF2A', 'EGR1', 'JAG1', 'EGR3', 'TRPC3', 'IDH2', 'PTPN11', 'PTPN14', 'TMEM170A', 'RHOA', 'ERN1', 'NR4A1', 'TFCP2', 'GRB2', 'CRK', 'ENG']",0.9999063297382558,0,0,31
401,Cell migration and invasion through p75NTR WP4561,0.9141658694893767,0.4033976124885216,0.03620221178953878,['RHOA'],0.9999063297382558,0,0,1
402,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.9141658694893767,0.4033976124885216,0.03620221178953878,['RBBP4'],0.9999063297382558,0,0,1
403,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9141658694893767,0.4033976124885216,0.03620221178953878,['RHOA'],0.9999063297382558,0,0,1
404,Sleep regulation WP3591,0.9141658694893767,0.4033976124885216,0.03620221178953878,['FOS'],0.9999063297382558,0,0,1
405,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.9177074784235778,0.590862030159802,0.05074121636753524,"['EIF4EBP1', 'PDGFA', 'GRB2', 'IGF1', 'EIF4E2']",0.9999063297382558,0,0,5
406,Male infertility WP4673,0.9191001978377039,0.6110904007455732,0.05155166770590998,"['GNAO1', 'MTHFD1', 'PARP1', 'XRCC5', 'MOV10L1', 'NOS1']",0.9999063297382558,0,0,6
407,Senescence and Autophagy in Cancer WP615,0.9227522040595345,0.5830431074309677,0.04687348737664652,"['BECN1', 'ING2', 'ATG16L1', 'CREG1', 'IGF1']",0.9999063297382558,0,0,5
408,Vitamin B12 metabolism WP1533,0.9228638201742252,0.38582930756843803,0.030971905885113872,['MMAB'],0.9999063297382558,0,0,1
409,Regulation of Microtubule Cytoskeleton WP2038,0.9230895396679604,0.46683926798127395,0.03736069835435709,"['PTPRA', 'MAPT']",0.9999063297382558,0,0,2
410,TGF-beta Receptor Signaling WP560,0.9230895396679604,0.46683926798127395,0.03736069835435709,"['FOS', 'ENG']",0.9999063297382558,0,0,2
411,Prolactin Signaling Pathway WP2037,0.9233322370182624,0.5540232793522267,0.04419230722561991,"['EIF4EBP1', 'PTPN11', 'GRB2', 'FOS']",0.9999063297382558,0,0,4
412,AGE/RAGE pathway WP2324,0.9267196334187059,0.5115280875564086,0.038929438046580535,"['CASP9', 'PRKCZ', 'RHOA']",0.9999063297382558,0,0,3
413,Aryl Hydrocarbon Receptor Pathway WP2873,0.9306808790755117,0.3697250280583614,0.026560614425203913,['JUNB'],0.9999063297382558,0,0,1
414,Wnt signaling in kidney disease WP4150,0.9306808790755117,0.3697250280583614,0.026560614425203913,['RHOA'],0.9999063297382558,0,0,1
415,MET in type 1 papillary renal cell carcinoma WP4205,0.9321024844667787,0.501838445781753,0.03528551996843865,"['PTPN11', 'GRB2', 'CRK']",0.9999063297382558,0,0,3
416,Integrated breast cancer pathway WP1984,0.9344378771511073,0.6374218009478673,0.043223656076368785,"['CASP9', 'MSH2', 'CDH1', 'ZMIZ1', 'DCAKD', 'DAG1', 'MAP3K13', 'RPP38', 'PML']",0.9999063297382558,0,0,9
417,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9353537542254589,0.4434299191374663,0.029634631896067257,"['NR1H2', 'ACOT2']",0.9999063297382558,0,0,2
418,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.9377062048537159,0.3549090909090909,0.02282725354034935,['PROM1'],0.9999063297382558,0,0,1
419,Nanoparticle-mediated activation of receptor signaling WP2643,0.9377062048537159,0.3549090909090909,0.02282725354034935,['GRB2'],0.9999063297382558,0,0,1
420,White fat cell differentiation WP4149,0.9377062048537159,0.3549090909090909,0.02282725354034935,['CEBPD'],0.9999063297382558,0,0,1
421,Ebola Virus Pathway on Host WP4217,0.9401262232324117,0.5776586368977673,0.035665298555061,"['CLTC', 'VPS41', 'HLA-C', 'EIF2AK2', 'EIF2S1', 'RHOA']",0.9999063297382558,0,0,6
422,Complement system WP2806,0.9407671724452698,0.4325816843074091,0.026413262742709193,"['FKBP2', 'SERPING1']",0.9999063297382558,0,0,2
423,Cardiac Progenitor Differentiation WP2406,0.9440199375737791,0.34123284123284126,0.019657739043278027,['IGF1'],0.9999063297382558,0,0,1
424,IL17 signaling pathway WP2112,0.9440199375737791,0.34123284123284126,0.019657739043278027,['CEBPD'],0.9999063297382558,0,0,1
425,Neovascularisation processes WP4331,0.9440199375737791,0.34123284123284126,0.019657739043278027,['JAG1'],0.9999063297382558,0,0,1
426,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.9440199375737791,0.34123284123284126,0.019657739043278027,['RHOA'],0.9999063297382558,0,0,1
427,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.94574783029844,0.422250032088307,0.023552815281703297,"['FOS', 'ENG']",0.9999063297382558,0,0,2
428,Pathways affected in adenoid cystic carcinoma WP3651,0.9461388661577238,0.474845872266641,0.026290282244299988,"['MORF4L1', 'PRKDC', 'ARID1A']",0.9999063297382558,0,0,3
429,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.9496941104399149,0.3285696470881656,0.016959232486693263,['CASP9'],0.9999063297382558,0,0,1
430,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.9496941104399149,0.3285696470881656,0.016959232486693263,['EIF4EBP1'],0.9999063297382558,0,0,1
431,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.9496941104399149,0.3285696470881656,0.016959232486693263,['CALM2'],0.9999063297382558,0,0,1
432,TYROBP causal network in microglia WP3945,0.9496941104399149,0.3285696470881656,0.016959232486693263,['ABCC4'],0.9999063297382558,0,0,1
433,Copper homeostasis WP3286,0.9503278097046867,0.4123989218328841,0.021011020302786152,"['SCO1', 'MAPT']",0.9999063297382558,0,0,2
434,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9503278097046867,0.4123989218328841,0.021011020302786152,"['FOS', 'MAP2K7']",0.9999063297382558,0,0,2
435,Wnt signaling WP428,0.9509998317800815,0.5335860660738837,0.026808107417911103,"['CSNK2A1', 'CTNNBIP1', 'CSNK1E', 'SENP2', 'RHOA']",0.9999063297382558,0,0,5
436,Modulators of TCR signaling and T cell activation WP5072,0.9545371361447297,0.40299558931634405,0.01875087304221778,"['DGKA', 'GRB2']",0.9999063297382558,0,0,2
437,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9547934691809704,0.3168109668109668,0.01465574645737694,['HDAC5'],0.9999063297382558,0,0,1
438,Prion disease pathway WP3995,0.9547934691809704,0.3168109668109668,0.01465574645737694,['FGFR1'],0.9999063297382558,0,0,1
439,Glioblastoma signaling pathways WP2261,0.9594336476651535,0.4853862791858466,0.02010087433433851,"['GRB2', 'MAP2K7', 'PRKCZ', 'FGFR1']",0.9999063297382558,0,0,4
440,Glucocorticoid Receptor Pathway WP2880,0.9619541762718409,0.3854154459158561,0.014949672865289943,"['PDE4B', 'BIRC2']",0.9999063297382558,0,0,2
441,PPAR signaling pathway WP3942,0.9619541762718409,0.3854154459158561,0.014949672865289943,"['ACOX3', 'SLC27A2']",0.9999063297382558,0,0,2
442,Vitamin A and carotenoid metabolism WP716,0.9634946369785738,0.29564534231200895,0.010994564632987648,['SULT1A1'],0.9999063297382558,0,0,1
443,B Cell Receptor Signaling Pathway WP23,0.964943671137087,0.47237067026540713,0.016856807751190275,"['BLNK', 'GRB2', 'PTPN11', 'CRK']",0.9999063297382558,0,0,4
444,Head and Neck Squamous Cell Carcinoma WP4674,0.9714687856537993,0.4152372724207687,0.012019516525297107,"['EIF4EBP1', 'BIRC2', 'FGFR1']",0.9999063297382558,0,0,3
445,MECP2 and Associated Rett Syndrome WP3584,0.9714687856537993,0.4152372724207687,0.012019516525297107,"['MECP2', 'CEBPD', 'IGF1']",0.9999063297382558,0,0,3
446,Focal Adhesion WP306,0.9731162008765839,0.5777848628159484,0.01574566513991911,"['RELN', 'FLT1', 'RASGRF1', 'PDGFA', 'GRB2', 'PARVB', 'IGF1', 'CRK', 'RHOA', 'BIRC2']",0.9999063297382558,0,0,10
447,Selenium Micronutrient Network WP15,0.9734542322547788,0.3544743935309973,0.009536945289806198,"['TXNRD1', 'KMO']",0.9999063297382558,0,0,2
448,Vitamin D-sensitive calcium signaling in depression WP4698,0.9735108850353597,0.2687072747678808,0.007213788826349821,['ATP2B3'],0.9999063297382558,0,0,1
449,Pancreatic adenocarcinoma pathway WP4263,0.973936032708617,0.44831650694408853,0.011839883083734461,"['CASP9', 'RALB', 'RALGDS', 'RHOA']",0.9999063297382558,0,0,4
450,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9761969890646601,0.2607843137254902,0.006282523575647377,['IGF1'],0.9999063297382558,0,0,1
451,Non-small cell lung cancer WP4255,0.9794110180058818,0.39069255483717424,0.008127924944985678,"['CASP9', 'RASSF1', 'GRB2']",0.9999063297382558,0,0,3
452,ErbB signaling pathway WP673,0.9807285688971588,0.4265808171959091,0.008301068983853098,"['EIF4EBP1', 'GRB2', 'MAP2K7', 'CRK']",0.9999063297382558,0,0,4
453,"GPCRs, Class A Rhodopsin-like WP455",0.9807285688971588,0.4265808171959091,0.008301068983853098,"['GPR173', 'EDNRA', 'CCKBR', 'SSTR2']",0.9999063297382558,0,0,4
454,Regulation of toll-like receptor signaling pathway WP1449,0.9807285688971588,0.4265808171959091,0.008301068983853098,"['TRAFD1', 'FOS', 'MAP2K7', 'RNF41']",0.9999063297382558,0,0,4
455,Small cell lung cancer WP4658,0.9807285688971588,0.4265808171959091,0.008301068983853098,"['CASP9', 'CCNE2', 'TRAF2', 'BIRC2']",0.9999063297382558,0,0,4
456,Nuclear Receptors Meta-Pathway WP2882,0.9816616368142735,0.5886399637927133,0.010894898906215261,"['EGR1', 'ABCC4', 'TXNRD1', 'SLC2A3', 'SULT1A1', 'DNAJC7', 'SLC39A9', 'FTH1', 'MAFF', 'PDE4B', 'BLVRB', 'JUNB', 'BIRC2']",0.9999063297382558,0,0,13
457,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9825012485351602,0.4780861943024105,0.008439973259959523,"['CAP1', 'PRKAB2', 'EIF4EBP1', 'MAP2K7', 'MAP3K13', 'CRK']",0.9999063297382558,0,0,6
458,Hippo-Merlin Signaling Dysregulation WP4541,0.9834610296141022,0.41648011431293164,0.006945749701347346,"['FLT1', 'CDH1', 'RBX1', 'FGFR1']",0.9999063297382558,0,0,4
459,Common Pathways Underlying Drug Addiction WP2636,0.9844810539797967,0.23326244905192273,0.0036483705843628773,['CALM2'],0.9999063297382558,0,0,1
460,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9872407891346716,0.30539548285156615,0.003921677664604066,"['CNTFR', 'IFNGR2']",0.9999063297382558,0,0,2
461,Toll-like Receptor Signaling Pathway WP75,0.9894006033870008,0.2951707097933513,0.0031453303279944684,"['FOS', 'MAP2K7']",0.9999063297382558,0,0,2
462,Chemokine signaling pathway WP3929,0.9895875126774298,0.42107970804797273,0.004407473533166921,"['GNB4', 'ADCY3', 'GRB2', 'PRKCZ', 'CRK']",0.9999063297382558,0,0,5
463,Regulation of Actin Cytoskeleton WP51,0.9899322062736258,0.44567340449693393,0.004509687492515136,"['PDGFA', 'FGF1', 'CRK', 'FGF22', 'RHOA', 'FGFR1']",0.9999063297382558,0,0,6
464,Adipogenesis WP236,0.9918084060665555,0.3763459384959945,0.0030955693112859027,"['CNTFR', 'CEBPD', 'TRIB3', 'IGF1']",0.9999063297382558,0,0,4
465,Phosphoinositides metabolism WP4971,0.9918316330768456,0.20136210590756046,0.0016515540357966451,['MTMR9'],0.9999063297382558,0,0,1
466,Ectoderm Differentiation WP2858,0.9922673762870482,0.40550334822119943,0.0031477908931074237,"['MECP2', 'ABCC4', 'GRAMD1B', 'ARHGEF9', 'RRBP1']",0.9999063297382558,0,0,5
467,Integrin-mediated Cell Adhesion WP185,0.9924776627467476,0.3317852326365475,0.0025052348843779136,"['CAPN5', 'GRB2', 'CRK']",0.9999063297382558,0,0,3
468,Hepatitis B infection WP4666,0.9933468195781949,0.39813615100583366,0.002657722635570593,"['CASP9', 'EGR3', 'GRB2', 'FOS', 'MAP2K7']",0.9999063297382558,0,0,5
469,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9952157250046975,0.18074623788909502,0.0008668149042288544,['PRKCZ'],0.9999063297382558,0,0,1
470,Pathways in clear cell renal cell carcinoma WP4018,0.9965705560755493,0.24575097334531296,0.0008442376441478461,"['FLT1', 'VHL']",0.9999063297382558,0,0,2
471,Endoderm differentiation WP2853,0.9968914718169629,0.33343518447788556,0.0010381069978284924,"['WNT8A', 'LEO1', 'RTF1', 'ELAVL1']",0.9999063297382558,0,0,4
472,DNA damage response (only ATM dependent) WP710,0.99918663546068,0.20314775226941786,0.0001653004118019047,"['GRB2', 'RHOA']",0.9999063297382558,0,0,2
473,Mesodermal commitment pathway WP2857,0.9998577523234008,0.16809138749839558,2.3912310103584468e-05,"['DLL1', 'FGFR1']",0.9999063297382558,0,0,2
474,Cytoplasmic Ribosomal Proteins WP477,0.9999063297382558,0.1026936026936027,9.619787194793797e-06,['MRPL19'],0.9999063297382558,0,0,1
